Company / Operating Income per Share
10x Genomics, Inc. Operating Income per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.50
FY2025
5-year range
-$2.30 / -$0.48
FY2021-FY2025
Trend
+69.5%
vs FY2024
Sector context
#110 of 149
Health Care
What the data says
At $-0.50, 10x Genomics, Inc.'s operating income per share ranks #110 of 149 in the Health Care sector. Operating Income per Share has fluctuated over the past 9 years, ranging from $-8.27 in FY2018 to $-0.48 in FY2021.
Based on SEC 10-K filings.
-0.50 in FY2025.
Improved from $-2.30 to $-0.50 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#110 of 149 in Health CareTop 74% of 149This company -$0.50 Sector average $4.30
▼
-111.6% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 69.5% year-over-year.
- Ranks #110 out of 149 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.50 | +69.5% |
| FY2024 | -$1.63 | +29.1% |
| FY2023 | -$2.30 | -54.3% |
| FY2022 | -$1.49 | -209.9% |
| FY2021 | -$0.48 | +91.3% |
| FY2020 | -$5.55 | -164.1% |
| FY2019 | -$2.10 | +74.6% |
| FY2018 | -$8.27 | -421.6% |
| FY2017 | -$1.59 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026